OpenAlex
PricingAboutJobs
Log inGet started
Work

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

HTML

Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(02)11469-3
Authors: Bengt I Eriksson, Peter Kälebo, David Bergqvisty, Ola E Dahl, Siv Lindbratt, Anders Bylock, Lars Frison, UG Eriksson, Lennart Welin, David Gustafsson
Institutions: Sahlgrenska University Hospital, Uppsala University Hospital, Oslo University Hospital, AstraZeneca (Sweden)
Language: English

Topic: Venous Thromboembolism Diagnosis and Management
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: ximelagatran, melagatran, dalteparin, venous thromboembolism, thromboprophylaxis, total hip arthroplasty, total knee arthroplasty, direct thrombin inhibitors, deep vein thrombosis, pulmonary embolism, dose-response relationship, postoperative bleeding, anticoagulant safety, heparin
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Akademiska Sjukhuset, Sahlgrenska Universitetssjukhuset
OpenAlex ID: W2167816835
FWCI: 59.48
Cites: 20
Cited by: 252
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms